Lyle W Ostrow

9PUBLICATIONS
48CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Molecular targetsNeurology and neuromuscular diseasesCancer therapy (excl. chemotherapy and radiation therapy)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 15, 2026
Somatic mosaicism in ALS and FTD identifies focal mutations associated with widespread degeneration.

|Oct 18, 2024
TDP43 aggregation at ER-exit sites impairs ER-to-Golgi transport.

Hongyi Wu, Loo Chien Wang, Belle M Sow

|Apr 25, 2024
Distinct transcriptomic profile of satellite cells contributes to preservation of neuromuscular junctions in extraocular muscles of ALS mice.

Ang Li, Jianxun Yi, Xuejun Li

|Dec 19, 2023
Biomarker Qualification for Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: Theory and Practice.

Michael Benatar, Lyle W Ostrow, Joseph W Lewcock

|Jun 26, 2023
Globally reduced N6-methyladenosine (m6A) in C9ORF72-ALS/FTD dysregulates RNA metabolism and contributes to neurodegeneration.

Yini Li, Xiaoyang Dou, Jun Liu

|Aug 09, 2022
Author Correction: Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4.

Laura Campisi, Shahab Chizari, Jessica S Y Ho

Pageof 2

Frequent Collaborators

2 joint publications

Frederick J Arnold

2 joint publications

Silvia De Rubeis

2 joint publications

Vladislav A Korobeynikov

2 joint publications

Ivan Marazzi